AstraZeneca licenses novel agent for treatment of cardiometabolic conditions, obesity Ruchika Sharma13 Nov 2023 3:00 PM ISTCambridge: AstraZeneca and Eccogene have entered into an exclusive licence agreement for ECC5004, an investigational oral once-daily...
AstraZeneca joins hands with Cellectis to accelerate development of next generation therapeutics Ruchika Sharma5 Nov 2023 4:00 PM ISTAstraZeneca has announced a collaboration and investment agreement with Cellectis, a clinical-stage biotechnology company, to accelerate the...
Zibotentan plus dapagliflozin demonstrated significant albuminuria reduction in patients with chronic kidney disease, proteinuria: AstraZeneca Ruchika Sharma5 Nov 2023 1:00 PM ISTCambridge: AstraZeneca has announced that the combination of zibotentan with dapagliflozin has shown statistically significant and clinically...
AstraZeneca gets CDSCO Panel Nod To Import, Market Andexanet alfa powder for solution for infusion Dr. Divya Colin27 Oct 2023 6:00 PM ISTNew Delhi: Pharmaceutical major AstraZeneca has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
AstraZeneca gets global online STARMAP license from Nanoform Finland Ruchika Sharma26 Oct 2023 2:30 PM ISTHelsinki: Nanoform Finland Plc., an innovative nanoparticle medicine-enabling company has announced that it has granted AstraZeneca Plc a global...
AstraZeneca self-administered nasal flu vaccine accepted for review by USFDA Ruchika Sharma25 Oct 2023 12:30 PM ISTCambridge: AstraZeneca’s Supplemental Biologics License Application (sBLA) for the approval of a self- or caregiver-administered option for...
AstraZeneca-Daiichi Sankyo Enhertu approved in EU for lung cancer Ruchika Sharma24 Oct 2023 1:30 PM ISTCambridge: AstraZeneca and Daiichi Sankyo’s (trastuzumab deruxtecan) has been approved in the European Union (EU) as monotherapy for the...
AstraZeneca Soliris approved in China for the treatment of adults with neuromyelitis optica spectrum disorder Ruchika Sharma22 Oct 2023 4:00 PM ISTCambridge: AstraZeneca has announced that Soliris (eculizumab) has been approved in China for the treatment of adult patients with neuromyelitis...
AstraZeneca gets USFDA priority review for Tagrisso plus chemotherapy for EGFR-mutated advanced lung cancer Ruchika Sharma17 Oct 2023 2:24 PM ISTCambridge: AstraZeneca’s supplemental New Drug Application (sNDA) for Tagrisso (osimertinib) in combination with chemotherapy has been accepted and...
AstraZeneca Forxiga meets primary endpoint for type 2 diabetes Ruchika Sharma8 Oct 2023 10:00 AM ISTCambridge: AstraZeneca has announced positive results from the T2NOW Phase III trial, one of the largest paediatric type 2 diabetes studies performed...
AstraZeneca settles Nexium, Prilosec product liability litigations for USD 425 million Ruchika Sharma4 Oct 2023 1:30 PM ISTAstraZeneca has entered into settlement agreements in the product liability litigations related to Nexium and Prilosec. The agreements effectively...
AstraZeneca gets CDSCO Panel Nod to study asthma drug Benralizumab Dr. Divya Colin22 Sept 2023 6:00 PM ISTNew Delhi: Pharmaceutical major, AstraZeneca has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
